Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection
- 8 March 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 34 (6) , 1887-1896
Abstract
Background Hepatitis B virus (HBV) infections are associated with an increased risk of kidney diseases. However, the effects of HBV infection on the prognosis of immunoglobulin A nephropathy (IgAN) are unclear. Methods A total of 838 patients with biopsy-confirmed IgAN were enrolled in this retrospective cohort study. The patients were categorized into either affected by IgAN and HBV infection (HBsAg-IgAN) or by primary IgAN with no sign of HBV infection (P-IgAN). A 1:1 propensity-score matching was performed between the two groups, followed by a Kaplan–Meier survival analysis, to compare the prognoses, and a Cox regression analysis, to identify factors influencing the HBsAg-IgAN outcomes. Results A total of 176 pairs of patients were successfully matched. A significant difference in the systolic blood pressure and urea, serum creatinine, uric acid, and 24-h urine protein levels was observed between the groups. A renal pathological analysis also revealed a significant difference in the mesangial hypercellularity between the groups. During a median follow-up period of 2.4 years, Kaplan–Meier analysis also revealed a significant difference in the renal survival between the groups. Furthermore, multivariate Cox analysis confirmed that HBV infection is an independent risk factor for IgAN progression (hazard ratio [HR] 2.096; 95% confidence interval [CI] 1.091–4.026). Finally, the HBsAg-IgAN patients who received treatment with renin–angiotensin–aldosterone system inhibitors had a better overall prognosis than those who received immunosuppressive therapy and antiviral treatment. Conclusion Our results indicate that the clinicopathological features and outcomes of patients with IgAN differ significantly between those with and without HBV infection, and that HBV is an independent risk factor for IgAN progression. Graphic abstractKeywords
Funding Information
- Natural Science Foundation of China (81700379)
- the program for scientific and technological innovation leader of Chongqing (CQYC201903084)
- Personal training Program for Clinical Medicine Research of Army Medical University (2018XLC1007)
This publication has 45 references indexed in Scilit:
- Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese populationNephrology Dialysis Transplantation, 2012
- Pathogenesis of IgA nephropathyNature Reviews Nephrology, 2012
- A Predictive Clinical Grading System for Immunoglobulin A Nephropathy by Combining Proteinuria and Estimated Glomerular Filtration RateNephron Clinical Practice, 2011
- Hepatitis B Virus Infection and the Dialysis PatientSeminars in Dialysis, 2008
- Early prediction of IgA nephropathy progression: Proteinuria and AOPP are strong prognostic markersKidney International, 2004
- Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritisKidney International, 1996
- IgA nephropathyKidney International, 1995
- Primary Glomerulonephritis with Detectable Glomerular Hepatitis B Virus AntigensAmerican Journal of Surgical Pathology, 1994
- Hepatitis-B-Associated GlomerulonephritisMedicine, 1990
- GLOMERULONEPHRITIS WITH DEPOSITION OF AUSTRALIA ANTIGEN-ANTIBODY COMPLEXES IN GLOMERULAR BASEMENT MEMBRANEThe Lancet, 1971